Use the 'Previous' and 'Next' buttons below to scroll through the Omega Pharma history.
Omega Pharma is created by two pharmacists, including Marc Coucke, the current CEO. With the slogan 'By pharmacists, for pharmacists' the founders of the Company began to build a Consumer Health organization in which the relationship with pharmacists plays a central role
Management buy-out by Marc Coucke
IPO on Euronext Brussels
Start of the acquisition process on the Belgian home market
Start of the internationalization process
Acquisition of Chefaro (AkzoNobel OTC) with operations in UK, Spain, Germany and The Netherlands
Expansion into France through the acquisition of Pharmygiène
Introduction in the Bel 20 index and expansion into Portugal
Expansion into Greece
Expansion into Italy and Scandinavia via acquisitions
Acquisition of 60 OTC brands from Pfizer which both expanded existing activities and provided access to new European countries such as Italy, Ireland, Scandinavia and Switzerland
Acquisition of Wartner Europe
Expansion into CEE and CIS through the acquisition of Bittner Pharma
Inclusion of Silence in the brand portfolio through the acquisition of Persee Médica
Arseus carve-out via separate IPO
Various smaller acquisitions, including Aurora (Australia, New Zealand, Singapore), Interdelta (Switzerland), Altermed (Czech Republic and Slovakia), O+A Pharma (Hungary), Hipocrate (Romania), Fishem (Turkey), and Cinetic Laboratories (Argentina)
Sale of 24% stake in Arseus
Formation of the 50/50 joint venture with Modi-Mundipharma Group in India
Acquisition of Laboratoire de la Mer, a world leader in natural Cough & Cold products
